Company page
Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. is a public company traded under the ticker RIGL in the American market. The company has a market capitalization of approximately $608.9 million. Rigel focuses on developing innovative therapies for various diseases, leveraging its expertise in drug discovery and development.
- Ticker
- RIGL:NASDAQ
- Asset type
- Stock
- Market cap
- $608.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD